Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-19

FDA Approved: FOSAMPRENAVIR CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for fosamprenavir calcium from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamprenavir calcium (fosamprenavir calcium)

Snippet

SUPPL AP for FOSAMPRENAVIR CALCIUM (FOSAMPRENAVIR CALCIUM)